Modulation of the physicochemical state of interior agents to prepare controlled release liposomes.
To prepare controlled release liposomes, freeze-drying of double emulsions (FDE) was employed to entrap a model drug, topotecan, which has been reported to tend to leak rapidly from vesicles. In addition, hydrogenated soy phosphatidylcholine (HSPC), N-(carbonyl-methoxypolyethyleneglycol2000)-1,2-distearoyl-sn-glycero-3-phosphoethanolamine (PEG-PE), and cholesterol (3:1:1, mass ratio) were used as the vesicle lipid. Different inner aqueous phases (W1) containing topotecan together with a variety of chemicals, such as citrate, sulfate, and divalent copper ions, were used to prepare W1/O/W2 double emulsions, which were then freeze-dried to obtain dry products. Upon rehydration, the dry products formed topotecan-entrapping unilamelar liposomes with an encapsulation efficiency of 80% and a mean diameter of less than 200nm. The in vitro release experiments demonstrated that the drug release of topotecan-entrapping FDE liposomes could be successfully controlled through altering the state of the incorporated drug by means of protonation, precipitation, or forming a transition metal-complex. Specifically, the formulation of 300mM CuSO(4) had a drug release half-life of 36h. This novel method is a promising way to prepare controlled release liposomes that are more suitable for therapeutic application. In addition, the liposome formation mechanism was discussed based on micrographs and the size of the double emulsions and vesicles, as well as the small angle X-ray scattering pattern and transmission electron microscopy images.
Wang
Ning
N
Department of Pharmacy, Jining Medical College, Rizhao City, Shandong Province, China.
Wang
Ting
T
Li
Tiefu
T
Deng
Yingjie
Y
D055598:Chemical Phenomena; D002784:Cholesterol / Q000737:chemistry; D003692:Delayed-Action Preparations / Q000138:chemical synthesis*; D004355:Drug Stability; D004655:Emulsions; D008081:Liposomes / Q000138:chemical synthesis*; D046529:Microscopy, Electron, Transmission; D010713:Phosphatidylcholines / Q000737:chemistry; D053838:Scattering, Small Angle; D012995:Solubility; D019772:Topotecan / Q000008:administration & dosage* / Q000737:chemistry; D014961:X-Ray Diffraction
D003692:Delayed-Action Preparations; D004655:Emulsions; D008081:Liposomes; C530904:N-(carbonyl-methoxypolyethyleneglycol2000)-1,2-distearoyl-sn-glycero-3-phosphoethanolamine; D010713:Phosphatidylcholines; D019772:Topotecan; D002784:Cholesterol